Abbott Laboratories Net Earnings
Net Income of Abbott Laboratories 2005-2021
Amounts are in $millions.
| Year | Net Income ($mn) |
| 2021 | $7,071 |
| 2020 | $4,495 |
| 2019 | $3,687 |
| 2018 | $2,368 |
| 2017 | $477 |
| 2016 | $1,400 |
| 2015 | $4,423 |
| 2014 | $2,284 |
| 2013 | $2,576 |
| 2012 | $5,963 |
| 2011 | $4,728 |
| 2010 | $4,626 |
| 2009 | $5,746 |
| 2008 | $4,734.2 |
| 2007 | $3,606.3 |
| 2006 | $1,716.8 |
| 2005 | $3,372.1 |
Abbott laboratories generated $7,071 million in net earnings in 2021 compared to $4,495 million in 2020.
The net earnings of Abbott Laboratories grew to $4,495 million in 2020 compared to $3,687 million in 2019. The company had net sales of $34,608 million in 2020 compared to $31,904 million in 2019.
Net Income of Abbott Laboratories increased to $2.37 billion in 2018 from $477 million in 2017.
About Abbott:
Abbott Laboratories is an Illinois corporation, incorporated in 1900. Its main business is the discovery, development, manufacture, and sale of a broad and diversified line of health care products.
Abbott has four reportable segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Cardiovascular and Neuromodulation Products.